首頁 > 市場調查報告書 > 醫療設備

眼科設備眼科藥物

市場調查報告書

商品編碼

1140734

全球弱視治療設備市場-2022-2029

Global Amblyopia Therapeutic Apparatus Market - 2022-2029

出版日期: 2022年10月20日 | 出版商:

DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

世界上不斷上升的殘疾和失明將推動市場增長。

醫療設備和技術支出的增加推動了市場增長。此外，全球殘疾和失明的增加也將推動預測期內的市場增長。例如：根據世界衛生組織 2021 年的數據，全球至少有 22 億人患有視力障礙或失明，其中至少有 10 億人患有本可以預防或尚未解決的視力障礙。我知道失明是未經治療的屈光不正（8840 萬）、白內障（9400 萬）、青光眼（770 萬）、角膜混濁（420 萬）、糖尿病視網膜病變（390 萬）、沙眼（200 萬）和未經治療的老花眼（8.26 億）人們）。此外，政府在世界各地治療兒童和青少年眼病方面的積極舉措預計將為未來一段時期的市場增長創造有利可圖的機會。

但是，熟練勞動力的短缺阻礙了市場的增長。有重要證據表明閉塞療法和阿托品可有效治療弱視。然而，弱視仍然難以診斷，主要是由於依從性問題和遮擋治療和阿托品處罰期間的護理結果不佳。對高技能專業人員的需求、弱視治療知識的缺乏以及培訓新專業人員的巨大成本限制了市場的增長。

地理滲透。

亞太地區是預測期內的主要地區。

本研究按地區分析了全球弱視治療設備市場，包括北美、歐洲、亞太地區、南美、中東和非洲。

由於醫療保健支出增加和技術進步，亞太地區已成為全球市場份額較高的領先地區。預計該地區也將在 2020-2026 年的預測期內表現出最高的增長率/複合年增長率。患有弱視的兒童人數不斷增長等因素為整個亞太地區的定制醫療弱視治療設備市場創造了豐厚的增長前景。此外，預計中東和非洲以及南美在預測期內也將以健康的複合年增長率增長。

據估計，北美和歐洲將佔據全球市場的很大份額。這些地區對眼科醫院的需求正在增加，視力恢復中心的數量也在增加。

競爭格局

弱視治療設備市場與來自美國、中國和印度等關鍵地區的主要市場參與者競爭適度。為全球市場增長做出貢獻的市場參與者包括廣州紡織、廣州世佳、西安華亞、深圳艾美迪、廣州世正、西安愛樂、中科恆通、北京通明等。領先公司正在為全球弱視治療設備市場的增長採取新產品引進和擴張戰略。 2022 年 1 月，全球醫療保健技術領導者美敦力 (Medtronic) 達成最終協議，收購總部位於波士頓地區的私營醫療技術公司 Affera, Inc.。此次收購將有助於擴大美敦力的心臟消融產品組合，包括首次進入地圖和導航，這是增長最快的醫療技術市場之一。 2021 年 10 月，FDA 批准了 Luminopia，這是一種用於改善懶惰兒童視力的數字療法。 Luminopia One 作為處方療法，適用於 4 至 7 歲患有弱視和各向異性或輕度斜視的兒童的視力增強。

COVID-19 的影響將對全球弱視治療設備市場產生負面影響。

由於 COVID-19 的全球負擔，預計對醫用弱視治療設備的需求將迅速增長。由於大流行，醫療弱視治療行業的供應商被迫暫停運營以遵守新的政府法規。此次磨合將對全球醫用弱視治療器械行業的銷售流量產生重大影響。

全球弱視治療設備市場報告包括大約 56 個市場數據表、41 個數字和 170 頁

Market Overview

Amblyopia Therapeutic Apparatus Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 2.9 % during the forecast period (2022-2029).

Amblyopia therapeutic apparatus is a device used to treat Amblyopia, often referred to as "lazy eye" Amblyopia is reduced vision in one or both eyes owing to abnormal vision production in infancy or childhood. There might not be an apparent issue with the eye in Amblyopia. Vision deficiency happens when the nerve impulses between the brain and the retina are not adequately activated. The brain "learns" to see only fuzzy images of an amblyopia eye, even though glasses are used. Consequently, one eye is favored by the brain, usually due to impaired vision with the other eye. Amblyopia therapeutic apparatus is widely used in homecare, hospitals and ophthalmologic centers. The growth of the amblyopia therapeutic apparatus market is the growing demand for amblyopia therapeutic apparatus due to rising healthcare expenditure and favorable government regulations.

Market Dynamics: The increasing prevalence of impairments or blindness incidence across the globe is driving the market's growth.

Growth in expenditure incurred on healthcare equipment and technology will propel the market's growth. Besides, the increasing prevalence of impairments or blindness across the globe drives the market's growth over the forecast years. For instance: as per World Health Organization 2021, at least 2.2 billion people worldwide have a vision impairment or blindness, of whom at least 1 billion have a vision impairment that could have been prevented or has yet to be addressed. Blindness is due to unaddressed refractive error (88.4 million), cataract (94 million), glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million), as well as near vision impairment caused by unaddressed presbyopia (826 million). Also, the favorable government initiatives taken regarding treating several eye diseases in the Children or Adolescents population across the globe are expected to create a lucrative opportunity for the market's growth over the forthcoming period.

However, the lack of a skilled workforce hampers market growth. Significant evidence has emerged for effective treatment of amblyopia, occlusion therapy and atropine. However, amblyopia diagnosis remains difficult, primarily due to compliance problems and sub-optimal care results during occlusion and atropine penalization. The requirement of skilled professionals for advanced technology, lack of knowledge about amblyopia therapeutic and huge costs incurred in training new professionals limit the market growth.

Market Segmentation: The color/Icon apparatus segment is projected to be the market's dominant segment during the forecast period.

Based on the product, the amblyopia therapeutic apparatus market has been classified into Color/Icon apparatus and comprehensive apparatus.

Color/Icon apparatus dominated the global market in 2021, whereas the organic amblyopia therapeutic apparatus is expected to present considerable growth shortly. Color/icon amblyopia therapeutic apparatus is much more appropriate for getting rid of amblyopia. Therefore, the increasing usage of color/Icon Apparatuses in the amblyopia therapeutic apparatus is expected to propel the near future segmental growth.

Amblyopia therapeutic apparatus is segmented based on application, which includes an eye hospital and vision recovery center.

Eye hospital segment held significant market share in global amblyopia therapeutic apparatus market. Most of this amblyopia therapeutic involves the diagnosis and treatment care of the patients for various amblyopia. These services are provided through public or private eye hospitals and clinics. The countries are developing their public and private hospitals to provide better medical treatments to the population. Moreover, the increasing number of overall treatments in hospitals includes procedures including Glasses and eye patches, further driving the market growth. According to the American Academy of Ophthalmology report published in 2021, According to the United States Census Bureau stated, the population of the United States is 289 million; among this, 151 million people require some form of vision correction, and 24% of the population (69 million people) is myopic, and it is estimated that about 43 million of these are candidates for refractive surgery. 60% have less than 2 diopters (D) of myopia, 39% have 2 to 8 D of myopia, and fewer than 1% have more than 8 D of myopia. Approximately 26% of the United States population (75 million people) are hyperopic, but only 15 million of these are candidates for refractive surgery. The average age of refractive surgery patients with myopia is 40 years, and with hyperopia, 55 years.

Geographical Penetration: Asia Pacific is the dominating region during the forecast period.

Based on geography, the study analyzes the amblyopia therapeutic apparatus market globally, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

The Asia Pacific is the leading/significant region globally in terms of market share due to the increasing growth in healthcare expenditure and technological advancement. In comparison, the region is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2026. Factors such as the rising population of children suffering from amblyopia would create lucrative growth prospects for the customized medical amblyopia therapeutic apparatus market across the Asia-Pacific region. Moreover, the Middle East & Africa and South America are also expected to grow with a healthy CAGR over the forecast period.

North America and Europe are estimated to hold a significant share in the global market. Increasing demand in eye hospitals across these regions also increases the number of vision recovery centers.

Competitive Landscape:

The amblyopia therapeutic apparatus market is moderately competitive, due to major market players in the key regions such as the US, China, India and others. Market players contributing to the growth of the global market include Guangzhou Boshi, Guangzhou Shijia, Xi'an Huaya, Shenzhen ElmmediCare, Guangzhou Shizheng, Xi'an Aile, Zhongke Hengtong, Beijing Tongming, among others. The major players are adopting new product launches and expansion strategies for global growth in the Amblyopia Therapeutic Apparatus market. In January 2022, Medtronic, a global leader in healthcare technology, has a definitive agreement to acquire Affera, Inc, a Boston area-based, privately held medical technology company. This acquisition helps to expand Medtronic's cardiac ablation portfolio, including first-time entry into mapping and navigation, within one of the fastest-growing MedTech markets. In October 2021, FDA approved Luminopia's digital therapeutic to enhance vision in children with lazy eyes. Luminopia One as a prescription therapy is indicated for enhancement in visual acuity in children with amblyopia aged between four and seven years and associated with anisometropia or mild strabismus.

COVID-19 Impact: Negative impact on the global amblyopia therapeutic apparatus market.

The demand for medical amblyopia therapeutic equipment is projected to expand rapidly due to the global burden of COVID-19. As a result of the pandemic, suppliers of the Medical Amblyopia Therapeutic Apparatus industry were forced to suspend their business operations to comply with the new government regulations. This break-in operation significantly affects the sales flow in the global industry for medical amblyopia.

The global amblyopia therapeutic apparatus market report would provide an access to approximately 56 market data tables, 41 figures and 170 pages

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

3.1. Market Snippet by Product
3.2. Market Snippet by Application
3.3. Market Snippet by Region

4. Amblyopia Therapeutic Apparatus Market-Market Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing HealthCare Expenditure boosts the market growth for Amblyopia Therapeutic Apparatus.
  - 4.1.1.2. Increasing demand from the e-commerce industry
- 4.1.2. Restraints:
  - 4.1.2.1. Lack of skilled workforce
- 4.1.3. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
7.3. Market Attractiveness Index, By Product Segment
- 7.3.1. Color/Icon Apparatus
  - 7.3.1.1. Introduction
  - 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 7.3.2. Comprehensive Apparatus

8. By Application

8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.3. Market Attractiveness Index, By Application Segment
- 8.3.1. Eye Hospital
  - 8.3.1.1. Introduction
  - 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 8.3.2. Vision Recovery Centre

9. By Region

9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.3. Market Attractiveness Index, By Region
9.4. North America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. The U.S.
  - 9.4.5.2. Canada
  - 9.4.5.3. Mexico
9.5. Europe
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. Germany
  - 9.5.5.2. The U.K.
  - 9.5.5.3. France
  - 9.5.5.4. Italy
  - 9.5.5.5. Spain
  - 9.5.5.6. Rest of Europe
9.6. South America
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 9.6.5.1. Brazil
  - 9.6.5.2. Argentina
  - 9.6.5.3. Rest of South America
9.7. Asia Pacific
- 9.7.1. Introduction
- 9.7.2. Key Region-Specific Dynamics
- 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 9.7.5.1. China
  - 9.7.5.2. India
  - 9.7.5.3. Japan
  - 9.7.5.4. Australia
  - 9.7.5.5. Rest of Asia Pacific
9.8. The Middle East and Africa
- 9.8.1. Introduction
- 9.8.2. Key Region-Specific Dynamics
- 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Amblyopia Therapeutic Apparatus Market- Company Profiles

11.1. Guangzhou Boshi
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Key Highlights
- 11.1.4. Financial Overview
11.2. Medtronic
11.3. Microlife
11.4. Guangzhou Shijia
11.5. Omron
11.6. Xi'an Huaya
11.7. Shenzhen ElmmediCare
11.8. Guangzhou Shizheng
11.9. Xi'an Aile
11.10. Zhongke Hengtong
11.11. Beijing Tongming (List Not Exhaustive)

12. Premium Insights

13. DataM Intelligence

13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

全球弱視治療市場規模調查：按治療類型、分銷渠道和地區劃分的預測（2022-2028 年）

弱視的全球市場預測(2021年～2028年)

FAQ

全球弱視治療設備市場-2022-2029